Brisbane’s Greenslopes Private Hospital is leading the way in an international ‘triple therapy’ heart study.
The hospital was the largest trial site in Australia for a global study focusing on the use of anticoagulants and antiplatelet therapies in high-risk cardiac patients.
Associate Professor David Colquhoun said the study’s findings will be discussed at a forthcoming research meeting of the Cardiology Craft Group and will lead to improved clinic practice.